HD Labs Tirzepatide Pen 30

Tirz epatide is a peptide widely utilized for its targeted activity across key metabolic pathways. It is designed to act on two primary receptors involved in glucose and energy regulation:

• GIP (glucose-dependent insulinotropic polypeptide)

• GLP-1 (glucagon-like peptide-1)

Through this dual-agonist mechanism, tirz epatide works by enhancing insulin secretion, suppressing glucagon secretion, regulating glucose production, slowing gastric emptying, and modulating appetite-related signaling.

Clinical Status

Unlike experimental single- or triple-agonist peptides still in development, tirz epatide is fully approved by major regulatory bodies (such as the FDA and EMA) for the treatment of type 2 diabetes and chronic weight management.

Important Information

• This product is supplied in a pre-mixed pen format
  

• Consultation with a licensed healthcare provider is essential prior to any consideration of use

• Results observed in clinical trials may not reflect real-world outcomes

WHAT YOU GET